Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 20 Dec 2024

Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kinetics

in Cancer Immunity and Immunotherapy

Mehdi Felfli
Alexandre Thinnes
Sebastien Jacques
Yan Liu
Antoine Iannessi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1470555

715 views

Original Research

Published on 20 Dec 2024

Spatially-resolved analyses of muscle invasive bladder cancer microenvironment unveil a distinct fibroblast cluster associated with prognosis

in Cancer Immunity and Immunotherapy

Chao Feng
Yaobang Wang
Wuyue Song
Tao Liu
Han Mo
Hui Liu
Shulin Wu
Zezu Qin
Zhenxing Wang
Yuting Tao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1522582

1,757 views

Original Research

Published on 20 Dec 2024

Unveiling the NEFH+ malignant cell subtype: Insights from single-cell RNA sequencing in prostate cancer progression and tumor microenvironment interactions

in Cancer Immunity and Immunotherapy

Jie Wang
Fu Zhao
Qiang Zhang
Zhou Sun
Zhikai Xiahou
Changzhong Wang
Yan Liu
Zongze Yu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1517679

2,736 views

Review

Published on 20 Dec 2024

Pinpointing the integration of artificial intelligence in liver cancer immune microenvironment

in Cancer Immunity and Immunotherapy

Ihtisham Bukhari
Mengxue Li
Guangyuan Li
Jixuan Xu
Pengyuan Zheng
Xiufeng Chu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1520398

878 views

Original Research

Published on 20 Dec 2024

Recursive partitioning staging system based on the log odds of the negative lymph node/T stage ratio in colon mucinous adenocarcinoma

in Cancer Immunity and Immunotherapy

Huajun Cai
Jintao Zeng
Ye Wang
Jinfu Zhuang
Xing Liu
Guoxian Guan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1472620

432 views

Original Research

Published on 19 Dec 2024

Dissecting the functions and regulatory mechanisms of disulfidoptosis-related RPN1 in pan-cancer: modulation of immune microenvironment and cellular senescence

in Cancer Immunity and Immunotherapy

Lexin Qin
Tingting Liang
Hailong Zhang
Xian Gong
Meidan Wei
Xiangrong Song
Yaoyu Hu
Xinyu Zhu
Wentao Hu
Jianxiang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1512445

920 views

Original Research

Published on 19 Dec 2024

High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC

in Cancer Immunity and Immunotherapy

Dagny Førde
Thomas Kilvær
Mona Irene Pedersen
Egil S Blix
Ilona Urbarova
Erna-Elise Paulsen
Mehrdad Rakaee
Lill-Tove Rasmussen Busund
Tom Donnem
Sigve Andersen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1504220

829 views

Original Research

Published on 19 Dec 2024

A novel liquid-liquid phase separation-related gene signature for predicting prognosis in colon cancer

in Cancer Immunity and Immunotherapy

Shuo Wang
Sen Hou
Shan Jiang
Chao Wang
Peipei Zhang
Yingjiang Ye
Zhidong Gao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1514613

1,012 views

Review

Published on 19 Dec 2024

Spatial transcriptomics in breast cancer: providing insight into tumor heterogeneity and promoting individualized therapy

in Cancer Immunity and Immunotherapy

Junsha An
Yajie Lu
Yuxi Chen
Yuling Chen
Zhaokai Zhou
Jianping Chen
Cheng Peng
Ruizhen Huang
Fu Peng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499301

1,752 views

Original Research

Published on 19 Dec 2024

Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer

in Cancer Immunity and Immunotherapy

Yulei Li
Lulu Zhang
Gang Xu
Gang Xu
Jiajun Chen
Keyuan Zhao
Mengyao Li
Jing Jin
Chao Peng
Kaifang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493528

956 views

Original Research

Published on 19 Dec 2024

Machine-learning derived identification of prognostic signature to forecast head and neck squamous cell carcinoma prognosis and drug response

in Cancer Immunity and Immunotherapy

Sha-Zhou Li
Hai-Ying Sun
Yuan Tian
Liu-Qing Zhou
Tao Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1469895

944 views

Original Research

Published on 18 Dec 2024

Diagnostic value of multi-tumor-associated autoantibody expression in esophageal squamous cell carcinoma and correlation of clinical features

in Cancer Immunity and Immunotherapy

Sihao Zhou
Kejun Liu
Yuyu Yang
Chuan Yuan
Yi Liu
Yi Liang
Wenhao Li
Jingjing Zhang
Hongyu Ye
Sheng Gong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1518431

473 views

Correction

Published on 18 Dec 2024

Corrigendum: Research progress of CD80 in the development of immunotherapy drugs

in Cancer Immunity and Immunotherapy

Lanying Li
Lei Yang
DePeng Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1538349

274 views

Review

Published on 18 Dec 2024

Tumor microenvironment in oral squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Chenxi Li
Xiaodan Dong
Bo Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1485174

1,478 views

General Commentary

Published on 18 Dec 2024

Commentary: Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: a multi-omics analysis with experimental verification

in Cancer Immunity and Immunotherapy

Jihao Xue
Qijia Yin
Ming Wang
Yanling Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1499286

350 views

Original Research

Published on 18 Dec 2024

Maternal immunization impairs lymphoma growth and CNS/ocular metastasis in the offspring

in Cancer Immunity and Immunotherapy

Ori Braitbard
Allan Bar-Sinai
Jacob Hochman

Frontiers in Immunology

doi 10.3389/fimmu.2024.1498272

569 views

Navigation group

Articles

Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kinetics

Spatially-resolved analyses of muscle invasive bladder cancer microenvironment unveil a distinct fibroblast cluster associated with prognosis

Unveiling the NEFH+ malignant cell subtype: Insights from single-cell RNA sequencing in prostate cancer progression and tumor microenvironment interactions

Pinpointing the integration of artificial intelligence in liver cancer immune microenvironment

Recursive partitioning staging system based on the log odds of the negative lymph node/T stage ratio in colon mucinous adenocarcinoma

Dissecting the functions and regulatory mechanisms of disulfidoptosis-related RPN1 in pan-cancer: modulation of immune microenvironment and cellular senescence

High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC

A novel liquid-liquid phase separation-related gene signature for predicting prognosis in colon cancer

Spatial transcriptomics in breast cancer: providing insight into tumor heterogeneity and promoting individualized therapy

Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer

Machine-learning derived identification of prognostic signature to forecast head and neck squamous cell carcinoma prognosis and drug response

Diagnostic value of multi-tumor-associated autoantibody expression in esophageal squamous cell carcinoma and correlation of clinical features

Corrigendum: Research progress of CD80 in the development of immunotherapy drugs

Tumor microenvironment in oral squamous cell carcinoma

Commentary: Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: a multi-omics analysis with experimental verification

Maternal immunization impairs lymphoma growth and CNS/ocular metastasis in the offspring